Cargando…

Economic evaluations of radioembolization with yttrium-90 microspheres in liver metastases of colorectal cancer: a systematic review

BACKGROUND: Transarterial radioembolization with yttrium-90 (Y-90 TARE) microspheres therapy has demonstrated positive clinical benefits for the treatment of liver metastases from colorectal cancer (lmCRC). This study aims to conduct a systematic review of the available economic evaluations of Y-90...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alonso, JC, Casans, I, González, FM, Fuster, D, Rodríguez, A, Sánchez, N, Oyagüez, I, Williams, AO, Espinoza, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210491/ https://www.ncbi.nlm.nih.gov/pubmed/37226091 http://dx.doi.org/10.1186/s12876-023-02793-5

Ejemplares similares

Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review
por: Alonso, J. C., et al.
Publicado: (2022)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
por: Gaba, Ron C., et al.
Publicado: (2012)

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
por: Bunck, Alexander C., et al.
Publicado: (2017)

Internal dosimetry for radioembolization therapy with Yttrium‐90 microspheres
por: Fallahpoor, Maryam, et al.
Publicado: (2017)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
por: Raval, Mihir, et al.
Publicado: (2014)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
por: Kim, S. Peter, et al.
Publicado: (2021)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
por: Roshan, Hoda Rezaei, et al.
Publicado: (2015)

Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis
por: Kim, Hyo-Cheol
Publicado: (2022)

Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases: A Single Institution Experience
por: Nace, Gary W., et al.
Publicado: (2011)

Side Effects of Yttrium-90 Radioembolization
por: Riaz, Ahsun, et al.
Publicado: (2014)

Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
por: Ebbers, S. C., et al.
Publicado: (2020)

Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma
por: Ghosh, Abheek, et al.
Publicado: (2022)

Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla
por: Sotirchos, Vlasios S., et al.
Publicado: (2014)

Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer
por: Puleo, Luciana, et al.
Publicado: (2022)

Radiographic Parameters in Predicting Outcome of Patients with Hepatocellular Carcinoma Treated with Yttrium-90 Microsphere Radioembolization
por: Salem, Mohamed E., et al.
Publicado: (2013)

A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma
por: Zhen, Yanhua, et al.
Publicado: (2019)

Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheres
por: Melucci, Elisa, et al.
Publicado: (2013)

Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
por: Henry, E. Courtney, et al.
Publicado: (2022)

Case Report of Cirrhosis following Yttrium-90 Radioembolization for Pancreatic Neuroendocrine Liver Metastases
por: Loree, Jonathan M., et al.
Publicado: (2016)

Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: A systematic review
por: Feretis, Michael, et al.
Publicado: (2020)

Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
por: Lu, Sen, et al.
Publicado: (2021)

Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer
por: Cohen, S J, et al.
Publicado: (2014)

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
por: Lee, Victor Ho-Fun, et al.
Publicado: (2015)

Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
por: Kallini, Joseph Ralph, et al.
Publicado: (2016)

History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
por: Saini, Aman, et al.
Publicado: (2019)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
por: Yu, Chun-Yen, et al.
Publicado: (2023)

Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study
por: Barakat, Elie, et al.
Publicado: (2021)

Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response
por: Rosenbaum, C. E. N. M., et al.
Publicado: (2016)

Correction: Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
por: Henry, E. Courtney, et al.
Publicado: (2023)

Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver Radioembolization
por: Elschot, Mattijs, et al.
Publicado: (2013)

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
por: Cappelli, Alberta, et al.
Publicado: (2014)

Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC
por: Veenstra, Emile B., et al.
Publicado: (2022)

Imaging evaluation following transarterial radioembolization with yttrium-90 microspheres downstaging hepatocellular carcinoma: the first case in China
por: Li, Xiaoming, et al.
Publicado: (2023)

Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience
por: Pellegrinelli, Julie, et al.
Publicado: (2021)

Yttrium-90 Radioembolization: An Unusual Cause of Radiating Abdominal Pain
por: Estes, Derek J., et al.
Publicado: (2019)

Transarterial radioembolization with Yttrium-90: current status and future prospects
por: Yang, Hua-Yu, et al.
Publicado: (2020)

Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres
por: Kao, Yung-Hsiang, et al.
Publicado: (2013)

Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres
por: Depalo, Tommaso, et al.
Publicado: (2021)

Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib
por: Teyateeti, Ajalaya, et al.
Publicado: (2021)

Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies
por: Janowski, E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8ao6pvmm4t4cptmkchgtleoln2